...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival.
【24h】

Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival.

机译:乳腺癌细胞质中组织蛋白酶D的浓度:与无病间隔和总体生存率的相关性。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cathepsin D (CD) is an aspartyl protease implicated in cancer metastasis. In this study of 331 patients, we show that patients with primary breast carcinomas containing high concentrations of CD have a significantly shorter disease-free interval (chi-square = 4.28, P 0.05) and overall survival (chi-square = 7.7, P 0.01) than patients with low concentrations. CD as a prognostic marker for overall survival was equally valuable for women younger (chi-square = 4.39, P 0.05) and older (chi-square = 3.97, P 0.05) than 50 years. CD was also a significant prognostic marker for overall survival within the estradiol receptor (ER)-positive subgroup of patients (chi-square = 5.79, P 0.025), but not in the ER-negative subgroup. Patients with tumors containing high concentrations of CD and low concentrations of ER had shorter disease-free intervals (chi-square = 15.1, P 0.001) and lower overall survival (chi-square = 20.9, P 0.001) than patients with high concentrations of ER but low concentrations of CD.
机译:组织蛋白酶D(CD)是一种天冬氨酰蛋白酶,与癌症转移有关。在331名患者的这项研究中,我们显示,含有高浓度CD的原发性乳腺癌患者的无病间隔时间(卡方= 4.28,P <0.05)和总体生存期(卡方= 7.7,P)显着缩短。 <0.01)低于低浓度患者。 CD作为总体生存的预后标志物,对于年龄小于50岁的女性(卡方= 4.39,P <0.05)和年龄较大(卡方= 3.97,P <0.05)的女性同样有价值。 CD还是患者雌二醇受体(ER)阳性亚组(卡方= 5.79,P <0.025)的整体生存的重要预后标志物,但在ER阴性亚组中不是。含有高浓度CD和低浓度ER的肿瘤患者的无病间隔时间短(卡方= 15.1,P <0.001)和较低的总体生存率(卡方= 20.9,P <0.001) ER,但CD浓度低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号